938P KN046 (an anti-PD-L1/CTLA-4 bispecific antibody) in combination with lenvatinib in the treatment for advanced unresectable or metastatic hepatocellular carcinoma (HCC): Preliminary efficacy and safety results of a prospective phase II trial

Annals of Oncology ◽

10.1016/j.annonc.2021.08.158 ◽

2021 ◽

Vol 32 ◽

pp. S822

Author(s):

B. Xing

Keyword(s):

Hepatocellular Carcinoma ◽

Phase Ii ◽

Bispecific Antibody ◽

Phase Ii Trial ◽

Efficacy And Safety ◽

Prospective Phase ◽

Metastatic Hepatocellular Carcinoma

Get full-text (via PubEx)

Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve

Journal of Hepatocellular Carcinoma ◽

10.2147/jhc.s206979 ◽

2019 ◽

Vol Volume 6 ◽

pp. 93-103 ◽

Cited By ~ 3

Author(s):

Nicholas Fidelman ◽

Curt Johanson ◽

Maureen Kohi ◽

Kanti Pallav Kolli ◽

Ryan Kohlbrenner ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Liver Transplant ◽

Phase Ii ◽

Phase Ii Trial ◽

Hepatic Reserve ◽

Prospective Phase ◽

Drug Eluting ◽

Transplant Candidates

Get full-text (via PubEx)

A phase II trial of continuous-infusion 5-fluorouracil, mitoxantone and cisplatin for metastatic hepatocellular carcinoma

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.4081 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4081-4081

Author(s):

M. Ikeda ◽

T. Okusaka ◽

H. Ueno ◽

Y. Takezako ◽

C. Morizane

Keyword(s):

Hepatocellular Carcinoma ◽

Continuous Infusion ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Hepatocellular Carcinoma

Get full-text (via PubEx)

FOXAI: a phase II trial evaluating the efficacy and safety of hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin for advanced hepatocellular carcinoma

Gut ◽

10.1136/gutjnl-2017-314138 ◽

2017 ◽

Vol 67 (2) ◽

pp. 395.1-396 ◽

Cited By ~ 9

Author(s):

Ning Lyu ◽

Youen Lin ◽

Yanan Kong ◽

Zhenfeng Zhang ◽

Longzhong Liu ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Hepatic Arterial Infusion ◽

Advanced Hepatocellular Carcinoma ◽

Efficacy And Safety ◽

Arterial Infusion

Get full-text (via PubEx)

A phase II trial of continuous-infusion 5-fluorouracil, mitoxantone and cisplatin for metastatic hepatocellular carcinoma

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.4081 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4081-4081

Author(s):

M. Ikeda ◽

T. Okusaka ◽

H. Ueno ◽

Y. Takezako ◽

C. Morizane

Keyword(s):

Hepatocellular Carcinoma ◽

Continuous Infusion ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Hepatocellular Carcinoma

Get full-text (via PubEx)

Combination treatment with transarterial chemoembolization, radiotherapy, and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumor thrombosis: Final results of a prospective phase II trial

Oncotarget ◽

10.18632/oncotarget.17072 ◽

2017 ◽

Vol 8 (32) ◽

pp. 52651-52664 ◽

Cited By ~ 2

Author(s):

Jeong Il Yu ◽

Hee Chul Park ◽

Sang Hoon Jung ◽

Changhoon Choi ◽

Sung Wook Shin ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Portal Vein ◽

Phase Ii ◽

Combination Treatment ◽

Transarterial Chemoembolization ◽

Phase Ii Trial ◽

Portal Vein Tumor Thrombosis ◽

Tumor Thrombosis ◽

Prospective Phase

Get full-text (via PubEx)

The Cd4/6 Inhibitor, Pd0332991, Has Activity in Metastatic Hepatocellular Carcinoma: Preliminary Results of a Phase II Trial

Annals of Oncology ◽

10.1093/annonc/mdt203.117 ◽

2013 ◽

Vol 24 ◽

pp. iv69 ◽

Cited By ~ 1

Author(s):

Susan Littman ◽

Ashlie Burkart ◽

Terry Hyslop ◽

Nancy Lewis ◽

Madhavan Pillai ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Preliminary Results ◽

Metastatic Hepatocellular Carcinoma

Get full-text (via PubEx)

Prospective phase II trial of sorafenib combined with doxorubicin eluting bead-transarterial chemoembolization for patients with unresectable hepatocellular carcinoma: efficacy analysis

Journal of Vascular and Interventional Radiology ◽

10.1016/j.jvir.2013.01.154 ◽

2013 ◽

Vol 24 (4) ◽

pp. S66-S67

Author(s):

A. Feng ◽

D. Reyes ◽

I. Kamel ◽

V. Gowdra Halappa ◽

C. Corona Villalobos ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase Ii ◽

Transarterial Chemoembolization ◽

Phase Ii Trial ◽

Efficacy Analysis ◽

Unresectable Hepatocellular Carcinoma ◽

Prospective Phase

Get full-text (via PubEx)

3535 POSTER Phase II trial investigating the efficacy and safety of sunitinib in patients with unresectable hepatocellular carcinoma (HCC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)71038-8 ◽

2007 ◽

Vol 5 (4) ◽

pp. 270 ◽

Cited By ~ 5

Author(s):

S.J. Faivre ◽

E. Raymond ◽

J. Douillard ◽

E. Boucher ◽

H.Y. Lim ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Efficacy And Safety ◽

Unresectable Hepatocellular Carcinoma

Get full-text (via PubEx)

47LBA Phase II trial of sorafenib with capecitabine and oxaliplatin (SECOX) in patients with locally advanced or metastatic hepatocellular carcinoma

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)72082-8 ◽

2009 ◽

Vol 7 (3) ◽

pp. 20-21 ◽

Cited By ~ 8

Author(s):

T. Yau ◽

P. Chan ◽

F.Y. Cheung ◽

A.S. Lee ◽

T.K. Yau ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Metastatic Hepatocellular Carcinoma

Get full-text (via PubEx)

Five-Years Outcome Analysis of 142 Consecutive Hepatocellular Carcinoma Patients Treated with Doxorubicin Eluting Microspheres 30–60 μm: Results from a Single-Centre Prospective Phase II Trial

CardioVascular and Interventional Radiology ◽

10.1007/s00270-019-02260-3 ◽

2019 ◽

Vol 42 (11) ◽

pp. 1551-1562 ◽

Cited By ~ 1

Author(s):

K. Malagari ◽

H. Moschouris ◽

Th. Kiakidis ◽

S. Harward ◽

A. Kelekis ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Outcome Analysis ◽

Single Centre ◽

Prospective Phase

Get full-text (via PubEx)